HIVACAT

CONTENT

Seminars and Congresses

11.11.12 - 13.11.12
2nd Antivirals Congress: From Bench to Bedside
Link del congréshttp://www.antivirals.elsevier.com/
11-13 November 2012 | Cambridge, MA, USA

The key objectives of this congress are:
- To provide a state-of-the-art report for scientists, health...
Més informació
21.05.12 - 22.05.12
RIBORED 2012 Valencia: V Reunión de la Red Temática Española de RNA
Venue
Campus de la Universidad Politécnica de Valencia (UPV)
Salón de actos de la Ciudad Politécnica de la...

Més informació
Publications and presentations related to the conference
- 22/05/2012 - Atenuación del VIH-1 mediante modificaciones del uso de parejas de codones en el genoma viral
  Glòria Martrus, Maria Nevot, Bonaventura Clotet y Miguel Angel Martínez. Irsicaixa AIDS Research Institute, University Hospital Germans Trias i Pujol of Badalona
21.05.12 - 21.05.12
Seminar on HIV: Treatment, prevention and eradication
Link del congréshttp://www.fvea.es/actividad_vih.html

The Fundación Valenciana de Estudios Avanzados organises a seminar on the treatment, the prevention and the eradication of the...

Més informació
Publications and presentations related to the conference
- 21/05/2012 - 12.45h. Puesta al día de los ensayos clínicos en fase III
  Christian Brander. ICREA Research Professor at IrsiCaixa. University Hospital Germans Trias i Pujol, Badalona.
- 21/05/2012 - 16.15h. Erradicación viral
  Javier Martínez-Picado. ICREA Research Professor at IrsiCaixa. University Hospital Germans Trias i Pujol, Badalona.
10.05.12 - 12.05.12
HIV, Cells of Macrophage/Dendritic Lineage, and Other Reservoirs: Pathogenic and Therapeutic Implications
Link del congréshttp://www.hiv-macrophages-reservoir.it

The 8th International Workshop “HIV, Cells of Macrophage/Dendritic Lineage, and Other Reservoirs: Pathogenic and Therapeutic Implications” will be held in Stresa...

Més informació
Publications and presentations related to the conference
- 12/05/2012 - Bitter-sweet attraction between HIV and mature dendritic cells
  VII SESSION. Myeloid cells in HIV coinfections and co-morbidities. 11.40 a.m.-12.00 p.m.
  Nuria Izquierdo. Irsicaixa AIDS Research Institute, University Hospital Germans Trias i Pujol of Badalona
- 11/05/2012 - HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T-cell activation (poster)
  Selected poster no. 10. Friday, May 11th, 2012 from 12.00h to 13.00h
  Maria T. Rodriguez-Plata¹, Alejandra Urrutia², Sylvain Cardinaud², Maria J. Buzón¹, Nuria Izquierdo-Useros¹, Julia G. Prado¹, Maria C. Puertas¹, Itziar Erkizia¹, Pierre-Grégoire Coulon², Samandhy Cedeño¹, Bonaventura Clotet¹, Arnaud Moris², Javier Martinez-Picado¹,³
  ¹AIDS Research Institute IrsiCaixa, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona; ²INSERM, Unité Mixte de Recherche Scientifique 945 (UMRS-945), Infection et Immunité, Université Pierre et Marie Curie; ³Institució Catalana de Recerca i Estudis Avançats, (ICREA)
05.03.12 - 08.03.12
CROI 2012 - 19th Conference on Retroviruses and Opportunistic Infections
Link del congréshttp://retroconference.org

Washington State Convention Center
Seattle, WA, US

*...

Més informació
Publications and presentations related to the conference
- 06/03/2012 - Effect of Maraviroc Intensification on the Decay of HIV-1 DNA in PBMC and Residual Viremia of Recently Infected Patients Initiating Treatment with Raltegravir plus Tenofovir/Emtricitabine: A 48-week Randomized Study (Poster - 351)
  Maria Puertas*1, J Llibre2, M Ballestero1, M Massanella1, M Buzon1, A Esteve3, J Miro4, J Blanco1, B Clotet1,2, J Martinez-Picado1,5, and the MARAVIBOOST Collaborative Group
  1AIDS Res Inst, Fndn irsiCaixa, Inst de Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain; 2Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain; 3Ctr for Epidemiological Studies on STI and HIV/AIDS of Catalonia, Badalona, Spain; 4Hosp Clin IDIBAPS, Univ of Barcelona, Spain; and 5Catalan Inst for Res and Advanced Studies, Barcelona, Spain
- 06/03/2012 - The Intracellular Disposition of Raltegravir Is Dependent on P-gp (ABCB1) Activity and Is Significantly Reduced in Primary CD4+ P-gphigh T Cells (Poster - 590)
  Gerard Minuesa*1, I Erkizia1, C Arimany-Nardi2, M Pastor-Anglada2, B Clotet1, and J Martinez-Picado1,3
  1AIDS Res Inst, Fndn irsiCaixa, Badalona, Spain; 2Univ of Barcelona Inst of BioMed i CIBERehd, Spain; and 3Inst Catalana de Recerca i Estudis Avançats, Barcelona, Spain
- 06/03/2012 - Simultaneous Pharmacogenetics-based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV+ Individuals (Poster - 623)
  Jose Molto*1,2, M Valle2,3, G Xinarianos4, C Miranda1, S Pushpakom4, S Cedeño5, B Clotet1,2,5, and A Owen4
  1Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain; 2Univ Autònoma de Barcelona, Spain; 3Inst de Recerca, Hosp de la Santa Creu i Sant Pau, Sant Pau Biomed Res Inst, Barcelona, Spain; 4Univ of Liverpool, UK; and 5Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Badalona, Spain
- 06/03/2012 - Compensatory Mutations Rescued Virus Replicative Capacity of VIRIP-resistant and VIR576-cross-resistant HIV-1 (Poster - 698)
  Emmanuel Gonzalez*1, E Ballana1, R Badia1, B Clotet1,2, and J Este1
  1Inst de Recerca de la SIDA, Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Badalona, Spain and 2Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain
- 07/03/2012 - Simultaneous Pharmacogenetics-based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV+ Individuals (Themed Discussion - 623)
  Jose Molto*1,2, M Valle2,3, G Xinarianos4, C Miranda1, S Pushpakom4, S Cedeño5, B Clotet1,2,5, and A Owen4
  1Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain; 2Univ Autònoma de Barcelona, Spain; 3Inst de Recerca, Hosp de la Santa Creu i Sant Pau, Sant Pau Biomed Res Inst, Barcelona, Spain; 4Univ of Liverpool, UK; and 5Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Badalona, Spain
- 07/03/2012 - HIV-1 Infection in a CCR5-D32/D32, HLA-B*5701, and HLA-A*2402 Subject: A Case Report (Poster - 292)
  Ester Ballana*, C Pou, M Permanyer, J Santos, R Paredes, C Brander, MA Martinez, B Clotet, and J Este
  Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Spain
- 07/03/2012 - Differences in Cytokine Levels in HIV-1+ Individuals Might Contribute to Natural Control of HIV Infection by Viremic Non-progressors (Poster - 297)
  Judith Dalmau*1, I Erkizia1, M Rotger2, A Rauch3, M Massanella1, E Palou4, B Clotet1, J Blanco1, A Telenti2, and J Martinez-Picado1,5
  1AIDS Res Inst, Fndn irsiCaixa, Badalona, Spain; 2Univ de Lausanne, Switzerland; 3Universitätsklinik für Infektiologie, Bern, Switzerland; 4Banc de Sang i Teixits, Barcelona, Spain; and 5Inst Catalana de Recerca i Estudis Avançats, Barcelona, Spain
- 07/03/2012 - Altering Immunodominance Hierarchy of p55gag by DNA Vaccine Expressing Conserved Regions (Poster - 427)
  George Pavlakis*1, V Kulkarni1, A Valentin1, M Rosati1, N Sardesai2, C Brander3, D Weiner4, M Rolland5, J Mullins6, and B Felber1
  1NCI-Frederick, MD, US; 2Inovio Pharmaceuticals, Blue Bell, PA, US; 3Fndn irsiCaixa, HIVACAT, Barcelona, Spain; 4Univ of Pennsylvania, Philadelphia, US; 5US Military HIV Res Prgm, Rockville, MD; and 6Univ of Washington, Seattle, US
- 07/03/2012 - Long-term Monotherapy with Lopinavir/ritonavir (>2 Years) Is Not Associated with Greater HIV-associated Neurocognitive Impairment (Poster - 483)
  José Santos*1, J Muñoz-Moreno1, J Molto1, I Bravo1, A Prats1, D McClernon2, A Curran3, P Domingo4, J Llibre1, and B Clotet5
  1Lluita contra la SIDA Fndn, Badalona, Spain; 2bioMONTR, Res Triangle Park, NC, US; 3Hosp Vall dʼHebron, Barcelona, Spain; 4Hosp de la Santa Creu i Sant Pau, Barcelona, Spain; and 5Fndn irsiCaixa, Badalona, Spain
- 07/03/2012 - Human Papillomavirus Infection in Anus, Penis and Mouth in HIV Infected Heterosexual and Men Who Have Sex With Men. The CARH·MEN Cohort Study (Poster - 895)
  S Videla1, L Darwich2,3, M-P Cañadas2,4, Josep Coll*2, M Piñol5, F Garcia-Cuyas5, R Molina-Lopez2, S Gel1, G Sirera1,5, B Clotet1,2,5, and HIV-HPV Can Ruti Study Group
  1Lluita contra la SIDA Fndn, Badalona, Spain; 2Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Badalona, Spain; 3Univ Autònoma de Barcelona, Bellaterra, Spain; 4Labco, GenLab, Barcelona, Spain; and 5Hosp Univ Germans Trias i Pujol, Badalona, Spain
- 08/03/2012 - HIV-1 Attenuation by Genome-scale Changes in Codon-pair Bias (Poster - 261)
  Gloria Martrus*1, M Nevot1, B Clotet1,2, and MA Martinez1
  1Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Spain and 2Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain
- 08/03/2012 - Evolution of HIV-1 Protease over 14 Years: Fitness Loss or Robustness Gain? (Poster - 263)
  Elena Capel-Malo*1, G Martrus1, M Parera1, B Clotet1,2, and MA Martinez1
  1Fndn irsiCaixa, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Spain and 2Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain
- 08/03/2012 - Altered Numbers, Frequency, and Phenotype of Treg from Virologically Suppressed HIV+ Individuals with Poor CD4 T Cell Recovery (Poster - 332)
  Marta Massanella*1,2, J Carrillo1, M Curriu1, J Pérez-Santiago3, J Puig4, B Clotet1,4, E Negredo4, J Blanco1,2, and the APOPVI Collaborative Group
  1Inst de Recerca de la SIDA, Fndn irsiCaixa, Badalona, Spain; 2Inst dʼInvestigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain; 3Univ of California, San Diego, La Jolla, US; and 4Lluita contra la SIDA Fndn, Badalona, Spain
- 08/03/2012 - Stable HIV-1 Integrase Diversity during Initial HIV-1 RNA Decay Suggests Complete Blockade of Plasma HIV-1 Replication by Effective Raltegravir-containing Salvage Therapy (Poster - 336)
  Marc Noguera-Julian*1, M Casadellà1, C Pou1, C Rodríguez1, S Pérez-Álvarez1, J Puig2, B Clotet1,2,3, and R Paredes1,2,3
  1AIDS Res Inst, Fndn irsiCaixa, Badalona, Spain; 2Lluita contra la SIDA Fndn, Badalona, Spain; and 3Univ Autònoma de Barcelona, Spain
- 08/03/2012 - 48-Week Raltegravir Intensification Shows Differing Effects on CD8 and CD4 T Cells in Treated HIV+ Individuals with Poor CD4 T Cell Recovery (Poster - 338)
  Marta Massanella*1, E Negredo2, M Buzon1, M Puertas1, J Puig2, N Perez-Alvarez2, J Martinez-Picado1,3, B Clotet1,2, J Blanco1,4, and the DiscorRal Collaborative Group
  1Inst de Recerca de la SIDA, irsiCaixa, Badalona, Spain; 2Lluita contra la SIDA Fndn, Badalona, Spain; 3Inst Catalana de Recerca i Estudis Avançats, Barcelona, Spain; and 4Inst dʼInvestigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
- 08/03/2012 - ARV Agents Effectively Block HIV Replication after Cell-to-Cell Transfer (Poster - 378)
  Marc Permanyer*, E Ballana, A Ruiz, B Clotet, and J Este
  AIDS Res Inst, Fndn irsiCaixa, Badalona, Spain
- 08/03/2012 - Significant Decrease of Viral Load with a Therapeutic Dendritic Cell-based Vaccine in Patients with Chronic HIV-1 Infection Receiving ART: A Phase 1/2 Blinded Randomized Placebo-controlled Study (Poster - 442)
  Felipe Garcia*1, N Climent1, C Gil1, A Leon1, B Autran2, J Lifson3, B Clotet4, J Gatell1, M Plana1, T Gallart1, and DCV2/MANON07-ORVACS Study Group
  1Hosp Clin IDIBAPS, HIVACAT, Univ of Barcelona, Spain; 2INSERM UMR S945, Univ Paris 6 Pierre and Marie Curie, Hosp Pitie-Salpetriere, France; 3AIDS and Cancer Virus Prgm, SAIC-Frederick, Inc, NCIFrederick, MD, US; and 4Hosp Univ Germans Trias i Pujol, Fndn irsiCaixa, HIVACAT, Badalona, Spain
- 08/03/2012 - Bayesian Network Analysis of Mutational Pathways to Darunavir Resistance (Poster - 703)
  Gertjan Beheydt*1, K Theys1, B Clotet2, E Schülter3, J-C Schmit4, A Sönnerborg5, M Zazzi6, K Van Laethem1, R Camacho7, and A-M Vandamme1
  1Katholieke Univ Leuven, Belgium; 2Fndn irsiCaixa, Badalona, Spain; 3Univ of Cologne, Germany; 4Ctr de Recherche Publ de la Santé, Luxembourg; 5Karolinska Inst, Stockholm, Sweden; 6Univ of Siena, Italy; and 7Inst de Higiene e Med Tropical, Lisbon, Portugal
- 08/03/2012 - Determination of HIV-1 Tropism from Proviral HIV-1 DNA in Patients with Suppressed Plasma HIV-1 RNA and Its Impact on Virologic Responses to Maraviroc (Poster - 716)
  Pantxika Bellecave*1, R Paredes2, V Soriano3, A-G Marcelin4, AM Geretti5, V Svicher6, D Descamps7, R Camacho8, R Kaiser9, B Masquelier10, and CHAIN WP2
  1UMR 5234, Bordeaux, France; 2AIDS Res Inst, Fndn irsiCaixa, Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Badalona, Spain; 3Hosp Carlos III, Madrid, Spain; 4Hosp Pitie-Salpetriere, Paris, France; 5Inst of Infection and Global Hlth, Univ of Liverpool, UK; 6Univ of Rome Tor Vergata, Italy; 7Bichat Claude Bernard Hosp, Paris, France; 8Lisboa Ocidenta Hosp, Lisbon, Portugal; 9Univ of Cologne, Germany; and 10Bordeaux Univ Hosp, France
- 08/03/2012 - Immune Status Plays a Key Role in Renal Recovery in Patients with Tenofovir-related Nephrotoxicity (Poster - 870)
  A Bonjoch1, P Echeverría1, N Perez-Alvarez1,2, J Puig1, C Estany1, B Clotet1,3, and Eugenia Negredo*1
  1Lluita contra la SIDA Fndn, Hosp Univ Germans Trias i Pujol, Autonomous Univ, Badalona, Spain; 2Tech Univ of Catalunya, Barcelona, Spain; and 3Fndn irsiCaixa, Barcelona, Spain
- 07/03/2012 - Mortality in Patients with Well-controlled HIV and High CD4 Counts in the cART Arms of the SMART and ESPRIT Randomized Clinical Trials Compared to the General Population (Poster - 638)
  Alison Rodger*1, R Lodwick1, M Schechter2, S Deeks3, J Amin4, R Gilson1, R Paredes5, E Bakowska6, F Engsig7, A Phillips1, for the INSIGHT ESPRIT & SMART Study Groups
  1Univ Coll London, UK; 2Univ Federal do Rio de Janeiro, Brazil; 3Univ of California, San Francisco, US; 4Univ of New South Wales, Sydney, Australia; 5Hosp Univ Germans Trias i Pujol, Badalona, Spain; 6Wojewodzki Szpital Zakazny, Warsaw, Poland; and 7Copenhagen Univ Hosp, Denmark

IrsiCaixa

Destacados

HIVACAT

Seminars and Congresses

2nd Antivirals Congress: From Bench to Bedside

RIBORED 2012 Valencia: V Reunión de la Red Temática Española de RNA

22/05/2012 - Atenuación del VIH-1 mediante modificaciones del uso de parejas de codones en el genoma viral

Seminar on HIV: Treatment, prevention and eradication

21/05/2012 - 12.45h. Puesta al día de los ensayos clínicos en fase III

21/05/2012 - 16.15h. Erradicación viral

HIV, Cells of Macrophage/Dendritic Lineage, and Other Reservoirs: Pathogenic and Therapeutic Implications

12/05/2012 - Bitter-sweet attraction between HIV and mature dendritic cells

11/05/2012 - HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T-cell activation (poster)

CROI 2012 - 19th Conference on Retroviruses and Opportunistic Infections

06/03/2012 - Effect of Maraviroc Intensification on the Decay of HIV-1 DNA in PBMC and Residual Viremia of Recently Infected Patients Initiating Treatment with Raltegravir plus Tenofovir/Emtricitabine: A 48-week Randomized Study (Poster - 351)

06/03/2012 - The Intracellular Disposition of Raltegravir Is Dependent on P-gp (ABCB1) Activity and Is Significantly Reduced in Primary CD4+ P-gphigh T Cells (Poster - 590)

06/03/2012 - Simultaneous Pharmacogenetics-based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV+ Individuals (Poster - 623)

06/03/2012 - Compensatory Mutations Rescued Virus Replicative Capacity of VIRIP-resistant and VIR576-cross-resistant HIV-1 (Poster - 698)

07/03/2012 - Simultaneous Pharmacogenetics-based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV+ Individuals (Themed Discussion - 623)

07/03/2012 - HIV-1 Infection in a CCR5-D32/D32, HLA-B5701, and HLA-A2402 Subject: A Case Report (Poster - 292)

07/03/2012 - Differences in Cytokine Levels in HIV-1+ Individuals Might Contribute to Natural Control of HIV Infection by Viremic Non-progressors (Poster - 297)

07/03/2012 - Altering Immunodominance Hierarchy of p55gag by DNA Vaccine Expressing Conserved Regions (Poster - 427)

07/03/2012 - Long-term Monotherapy with Lopinavir/ritonavir (>2 Years) Is Not Associated with Greater HIV-associated Neurocognitive Impairment (Poster - 483)

07/03/2012 - Human Papillomavirus Infection in Anus, Penis and Mouth in HIV Infected Heterosexual and Men Who Have Sex With Men. The CARH·MEN Cohort Study (Poster - 895)

08/03/2012 - HIV-1 Attenuation by Genome-scale Changes in Codon-pair Bias (Poster - 261)

08/03/2012 - Evolution of HIV-1 Protease over 14 Years: Fitness Loss or Robustness Gain? (Poster - 263)

08/03/2012 - Altered Numbers, Frequency, and Phenotype of Treg from Virologically Suppressed HIV+ Individuals with Poor CD4 T Cell Recovery (Poster - 332)

08/03/2012 - Stable HIV-1 Integrase Diversity during Initial HIV-1 RNA Decay Suggests Complete Blockade of Plasma HIV-1 Replication by Effective Raltegravir-containing Salvage Therapy (Poster - 336)

08/03/2012 - 48-Week Raltegravir Intensification Shows Differing Effects on CD8 and CD4 T Cells in Treated HIV+ Individuals with Poor CD4 T Cell Recovery (Poster - 338)

08/03/2012 - ARV Agents Effectively Block HIV Replication after Cell-to-Cell Transfer (Poster - 378)

08/03/2012 - Significant Decrease of Viral Load with a Therapeutic Dendritic Cell-based Vaccine in Patients with Chronic HIV-1 Infection Receiving ART: A Phase 1/2 Blinded Randomized Placebo-controlled Study (Poster - 442)

08/03/2012 - Bayesian Network Analysis of Mutational Pathways to Darunavir Resistance (Poster - 703)

08/03/2012 - Determination of HIV-1 Tropism from Proviral HIV-1 DNA in Patients with Suppressed Plasma HIV-1 RNA and Its Impact on Virologic Responses to Maraviroc (Poster - 716)

08/03/2012 - Immune Status Plays a Key Role in Renal Recovery in Patients with Tenofovir-related Nephrotoxicity (Poster - 870)

07/03/2012 - Mortality in Patients with Well-controlled HIV and High CD4 Counts in the cART Arms of the SMART and ESPRIT Randomized Clinical Trials Compared to the General Population (Poster - 638)

IrsiCaixa

Destacados

HIVACAT

Seminars and Congresses

2nd Antivirals Congress: From Bench to Bedside

RIBORED 2012 Valencia: V Reunión de la Red Temática Española de RNA

22/05/2012 - Atenuación del VIH-1 mediante modificaciones del uso de parejas de codones en el genoma viral

Seminar on HIV: Treatment, prevention and eradication

21/05/2012 - 12.45h. Puesta al día de los ensayos clínicos en fase III

21/05/2012 - 16.15h. Erradicación viral

HIV, Cells of Macrophage/Dendritic Lineage, and Other Reservoirs: Pathogenic and Therapeutic Implications

12/05/2012 - Bitter-sweet attraction between HIV and mature dendritic cells

11/05/2012 - HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T-cell activation (poster)

CROI 2012 - 19th Conference on Retroviruses and Opportunistic Infections

06/03/2012 - Effect of Maraviroc Intensification on the Decay of HIV-1 DNA in PBMC and Residual Viremia of Recently Infected Patients Initiating Treatment with Raltegravir plus Tenofovir/Emtricitabine: A 48-week Randomized Study (Poster - 351)

06/03/2012 - The Intracellular Disposition of Raltegravir Is Dependent on P-gp (ABCB1) Activity and Is Significantly Reduced in Primary CD4+ P-gphigh T Cells (Poster - 590)

06/03/2012 - Simultaneous Pharmacogenetics-based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV+ Individuals (Poster - 623)

06/03/2012 - Compensatory Mutations Rescued Virus Replicative Capacity of VIRIP-resistant and VIR576-cross-resistant HIV-1 (Poster - 698)

07/03/2012 - Simultaneous Pharmacogenetics-based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV+ Individuals (Themed Discussion - 623)

07/03/2012 - HIV-1 Infection in a CCR5-D32/D32, HLA-B*5701, and HLA-A*2402 Subject: A Case Report (Poster - 292)

07/03/2012 - Differences in Cytokine Levels in HIV-1+ Individuals Might Contribute to Natural Control of HIV Infection by Viremic Non-progressors (Poster - 297)

07/03/2012 - Altering Immunodominance Hierarchy of p55gag by DNA Vaccine Expressing Conserved Regions (Poster - 427)

07/03/2012 - Long-term Monotherapy with Lopinavir/ritonavir (>2 Years) Is Not Associated with Greater HIV-associated Neurocognitive Impairment (Poster - 483)

07/03/2012 - Human Papillomavirus Infection in Anus, Penis and Mouth in HIV Infected Heterosexual and Men Who Have Sex With Men. The CARH·MEN Cohort Study (Poster - 895)

08/03/2012 - HIV-1 Attenuation by Genome-scale Changes in Codon-pair Bias (Poster - 261)

08/03/2012 - Evolution of HIV-1 Protease over 14 Years: Fitness Loss or Robustness Gain? (Poster - 263)

08/03/2012 - Altered Numbers, Frequency, and Phenotype of Treg from Virologically Suppressed HIV+ Individuals with Poor CD4 T Cell Recovery (Poster - 332)

08/03/2012 - Stable HIV-1 Integrase Diversity during Initial HIV-1 RNA Decay Suggests Complete Blockade of Plasma HIV-1 Replication by Effective Raltegravir-containing Salvage Therapy (Poster - 336)

08/03/2012 - 48-Week Raltegravir Intensification Shows Differing Effects on CD8 and CD4 T Cells in Treated HIV+ Individuals with Poor CD4 T Cell Recovery (Poster - 338)

08/03/2012 - ARV Agents Effectively Block HIV Replication after Cell-to-Cell Transfer (Poster - 378)

08/03/2012 - Significant Decrease of Viral Load with a Therapeutic Dendritic Cell-based Vaccine in Patients with Chronic HIV-1 Infection Receiving ART: A Phase 1/2 Blinded Randomized Placebo-controlled Study (Poster - 442)

08/03/2012 - Bayesian Network Analysis of Mutational Pathways to Darunavir Resistance (Poster - 703)

08/03/2012 - Determination of HIV-1 Tropism from Proviral HIV-1 DNA in Patients with Suppressed Plasma HIV-1 RNA and Its Impact on Virologic Responses to Maraviroc (Poster - 716)

08/03/2012 - Immune Status Plays a Key Role in Renal Recovery in Patients with Tenofovir-related Nephrotoxicity (Poster - 870)

07/03/2012 - Mortality in Patients with Well-controlled HIV and High CD4 Counts in the cART Arms of the SMART and ESPRIT Randomized Clinical Trials Compared to the General Population (Poster - 638)

07/03/2012 - HIV-1 Infection in a CCR5-D32/D32, HLA-B5701, and HLA-A2402 Subject: A Case Report (Poster - 292)